Genome-wide gene-asbestos exposure interaction association study identifies a common susceptibility variant on 22q13.31 associated with lung cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1564-1573

  Liu, Chen Yu ^a,b   Stücker, Isabelle ^c   Chen, Chu ^d,e,f   Goodman, Gary ^d   McHugh, Michelle K ^g   D'Amelio, Anthony M ^g,h   Etzel, Carol J ^g   Li, Su ^a   Lin, Xihong ^a   Christiani, David C ^a,i  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSERM   (France)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; DNA;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CAUCASIAN; CHEMOPROPHYLAXIS; CHROMOSOME 22Q; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENHANCER REGION; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADVERSE EFFECTS; CHEMICALLY INDUCED; EPISTASIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; INCIDENCE; LUNG NEOPLASMS; MASSACHUSETTS; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ASBESTOS; BOSTON; DNA, NEOPLASM; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84942910862     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0021     Document Type: Article

References (74)

1. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996;14: 466-80.
2. International Agency for Research on Cancer (IARC). Overall Evaluation of Carcinogenicity: An updating of IARC monographs volumes 1-42. Lyon, France: IARC; 1987. IARC Monographs on the evaluation of carcinogenic risks to humans, suppl.7.
3. Kazan-Allen L. The international ban asbestos secretariat. Int J Occup Environ Health 2000;6:164.
4. Ramazzini C. Asbestos is still with us: repeat call for a universal ban. Am J Ind Med 2011;54:168-73.
5. Institue of Medicine. Asbestos: Selected Cancers. Washington, DC: National Academies Press; 2006.
6. LaDou J. The asbestos cancer epidemic. Environ Health Persp 2004; 112:285-90.
7. Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Publ Health 2013;34:205-16.
8. World Health Organization.(WHO). Asbestos: elimination of asbestosrelated diseases. Fact sheet No. 343. http://www.who.int/mediacentre/factsheets/fs343/en/Date Accessed: July 2010.
9. Tossavainen A. International expert meeting on new advances in the radiology and screening of asbestos-related diseases. Scand J Work Environ Health 2000;26:449-54.
10. Doll R. Mortality from lung cancer in asbestos workers. Br J Ind Med 1955;12:81-6.
11. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA 1964;188:22-6.
12. Martischnig KM, Newell DJ, Barnsley WC, Cowan WK, Feinmann EL, Oliver E. Unsuspected exposure to asbestos and bronchogenic carcinoma. Br Med J 1977;1:746-9.
13. Blot WJ, Harrington JM, Toledo A, Hoover R, Heath CW Jr, Fraumeni JF Jr Lung cancer after employment in shipyards during World War II. N Engl J Med 1978;299:620-4.
14. IARC: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer. 1987.
15. Markowitz SB, Levin SM, Miller A, Morabia A. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Resp Crit Care 2013;188:90-6.
16. Bignon J, Housset B, Brochard P, Pairon JC. Asbestos-related occupational lung diseases. Role of the pneumology unit in screening and compensation. Rev Mal Respir 1999;16:S42-8.
17. Christiani DC. Smoking and the molecular epidemiology of lung cancer. Clin Chest Med 2000;21:87-93, viii.
18. Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW, Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med 2002;42: 29-37.
19. Schneider J, Bernges U. CYP1A1 and CYP1B1 polymorphismsasmodifying factors in patients with pneumoconiosis and occupationally related tumours: A pilot study. Mol Med Report 2009;2:1023-8.
20. Stucker I, Boffetta P, Antilla S, Benhamou S, Hirvonen A, London S, et al. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis. Cancer Epidemiol Biomarkers Prev 2001;10:1253-8.
21. Wang LI, Neuberg D, Christiani DC. Asbestos exposure, manganese superoxide dismutase(MnSOD) genotype, and lung cancer risk. J Occup Environ Med 2004;46:556-64.
22. Wei S, Wang LE, McHugh MK, Han Y, Xiong M, Amos CI, et al. Genomewide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis 2012;33:1531-7.
23. Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 2002;62:2819-23.
24. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
25. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-34.
26. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-22.
27. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestosexposed workers. Cancer Res 1994;54:2038s-43s.
28. Cullen MR, Barnett MJ, Balmes JR, Cartmel B, Redlich CA, Brodkin CA, et al. Predictors of lung cancer among asbestos-exposed men in the {beta}- carotene and retinol efficacy trial. Am J Epidemiol 2005;161:260-70.
29. Luce D, Stucker I, Group IS. Investigation of occupational and environmental causes of respiratory cancers (ICARE): A multicenter, populationbased case-control study in France. BMC Public Health 2011;11:928.
30. Sprince NL, Oliver LC, McLoud TC, Eisen EA, Christiani DC, Ginns LC. Asbestos exposure and asbestos-related pleural and parenchymal disease. Associations with immune imbalance. Am Rev Respir Dis 1991; 143:822-8.
31. Barnhart S, Keogh J, Cullen MR, Brodkin C, Liu D, Goodman G, et al. The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohorts. Am J Ind Med 1997;32: 573-81.
32. Guida F, Paget-Bailly S, Lamkarkach F, Gaye O, Ducamp S, Menvielle G, et al. Risk of lung cancer associated with occupational exposure tomineral wools: updating knowledge from a French population-based case-control study, the ICARE study. J Occup Environ Med 2013;55:786-95.
33. Hutter CM, Mechanic LE, Chatterjee N, Kraft P, Gillanders EM, Tank NCIGET. Gene-environment interactions in cancer epidemiology: A national cancer institute think tank report. Genet Epidemiol 2013;37:643-57.
34. Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M, et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res 2015;43:D670-81. Genome Browser Website. http://genome.ucsc.edu/index.html. [Accessed March 2015].
35. Kent WJ, Sugnet CW, Furey TS, RoskinKM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
36. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37:W600-5.
37. Dayem Ullah AZ, Lemoine NR, Chelala C. SNPnexus: A web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res 2012;40:W65-W70.
38. Chelala C, Khan A, Lemoine NR. SNPnexus: A web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms. Bioinformatics 2009;25:655-61.
39. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-7.
40. Ward LD, Kellis M. Haplo reg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-4.
41. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
42. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
43. De Rienzo A, Testa JR. Recent advances in the molecular analysis of human malignant mesothelioma. La Clinica Terapeutica 2000;151: 433-8.
44. Nymark P, Wikman H, Ruosaari S, Hollmen J, Vanhala E, Karjalainen A, et al. Identification of specific gene copy number changes in asbestosrelated lung cancer. Cancer Res 2006;66:5737-43.
45. Bjorkqvist AM, Tammilehto L, Nordling S, NurminenM, Anttila S, Mattson K, et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998;77:260-9.
46. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
47. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5.
48. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005;11:241-7.
49. Zhang B, Zhou Y, Lin N, Lowdon RF, Hong C, Nagarajan RP, et al. Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res 2013;23:1522-40.
50. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000;408:86-9.
51. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713-22.
52. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64:3753-6.
53. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
54. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47.
55. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, et al. The let-7 microRNAreduces tumor growth in mouse models of lung cancer. Cell Cycle 2008;7:759-64.
56. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008;105: 3903-8.
57. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Gene Dev 2007;21:1025-30.
58. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007;315:1576-9.
59. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007;6:2585-90.
60. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007;67:9762-70.
61. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109-23.
62. Swaminathan S, Suzuki K, Seddiki N, Kaplan W, Cowley MJ, Hood CL, et al. Differential regulation of the Let-7 family of microRNAs in CD4 T cells alters IL-10 expression. J Immunol 2012;188:6238-46.
63. Driscoll KE, Carter JM, Howard BW, Hassenbein D, Burdick M, Kunkel SL, et al. Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. Am J Physiol 1998;275:L887-94.
64. Huaux F, Louahed J, Hudspith B, Meredith C, Delos M, Renauld JC, et al. Role of interleukin-10 in the lung response to silica in mice. Am J Resp Cell Mol 1998;18:51-9.
65. Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev 2011;14:179-245.
66. Dopp E, Schiffmann D. Analysis of chromosomal alterations induced by asbestos and ceramic fibers. Toxicol Lett 1998;96-97:155-62.
67. Lohani M, Dopp E, Becker HH, Seth K, Schiffmann D, Rahman Q. Smoking enhances asbestos-induced genotoxicity, relative involvement of chromosome 1: A study using multicolor FISH with tandem labeling. Toxicol Lett 2002;136:55-63.
68. Patel JD. Lung cancer in women. J Clin Oncol 2005;23:3212-8.
69. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: Emerging differences in epidemiology, biology, and therapy. Chest 2005;128: 370-81.
70. Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: Epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007;55:15-23.
71. Paggi MG, Vona R, Abbruzzese C, Malorni W. Gender-related disparities in non-small cell lung cancer. Cancer Lett 2010;298:1-8.
72. Sharma S, Eghbali M. Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ 2014;5:3.
73. Pinto R, Pilato B, Ottini L, Lambo R, Simone G, Paradiso A, et al. Different methylation and microRNA expression pattern in male and female familial breast cancer. J Cell Physiol 2013;228:1264-9.
74. Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, et al. Genetic susceptibility to malignant pleuralmesothelioma and other asbestos- Associated diseases. Mutat Res 2008;659:126-36.